Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68

BACKGROUND: Despite availability of efficient treatment regimens for early stage colorectal cancer, treatment regimens for late stage colorectal cancer are generally not effective and thus need improvement. Oncolytic virotherapy using replication-competent vaccinia virus (VACV) strains is a promisin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrig, Klaas, Kilinc, Mehmet O, Chen, Nanhai G, Stritzker, Jochen, Buckel, Lisa, Zhang, Qian, Szalay, Aladar A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621142/
https://www.ncbi.nlm.nih.gov/pubmed/23531320
http://dx.doi.org/10.1186/1479-5876-11-79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621142/
https://www.ncbi.nlm.nih.gov/pubmed/23531320
http://dx.doi.org/10.1186/1479-5876-11-79

Ejemplares similares